Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice

Documenti analoghi

• A multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice ( PIONEER REAL Japan): Subgroup analyses
  di: Daisuke Yabe, et al.
  Pubblicazione: (2025)
• PIONEER REAL Japan: Primary results from a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice
  di: Daisuke Yabe, et al.
  Pubblicazione: (2024)
• PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan
  di: Ryo Suzuki, et al.
  Pubblicazione: (2024)
• Accelerating innovation and ensuring the thoughtful withdrawal of lifeline medicines for people living with diabetes in Asia
  di: Yutaka Seino, et al.
  Pubblicazione: (2025)
• The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma
  di: Yutaka Seino, et al.
  Pubblicazione: (2024)